RxPG News Feed for RxPG News

Medical Research Health Special Topics World
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
  Anorexia Nervosa
  Child Psychiatry
  Forensic Psychiatry
  Mood Disorders
  Peri-Natal Psychiatry
  Personality Disorders
  Sleep Disorders
  Substance Abuse
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Oct 11, 2012 - 10:22:56 PM
Systematic Review
British Journal of Psychiatry
Suicide Channel

subscribe to Suicide newsletter
Latest Research : Psychiatry : Suicide

   EMAIL   |   PRINT
Schizophrenia and suicide: systematic review of risk factors.

Jul 5, 2005 - 10:23:00 PM
Positive psychotic symptoms were not associated with increased risk. Indeed, hallucinations were actually associated with decreased risk, as were delusions. It is likely that the negative symptoms of schizophrenia are also associated with decreased risk of suicide.

[RxPG] The most comprehensive review of the international evidence to date on suicide in schizophrenia has found that the key risk factors are: depression, previous suicide attempts, drug misuse, agitation or restlessness, fear of mental disintegration, poor compliance with treatment and recent loss.

Suicide risk is greatly increased in schizophrenia, and detection of those at risk is clinically important. Published in the July issue of the British Journal of Psychiatry, this study systematically reviewed the world literature on patients with schizophrenia or related conditions in which suicide was reported.

28 eligible studies were identified. It was found that suicide risk in patients with schizophrenia was related less to the core psychotic symptoms of the disorder, such as hallucinations and delusions, and more to affective symptoms, agitation or restlessness, and to awareness that the illness was affecting mental functioning.

Previous suicidal behaviour was a strong risk factor. Drug misuse and loss also appeared to increase risk. Compliance with treatment was important in reducing risk.

Positive psychotic symptoms were not associated with increased risk. Indeed, hallucinations were actually associated with decreased risk, as were delusions. It is likely that the negative symptoms of schizophrenia are also associated with decreased risk of suicide.

Although this meta-analysis has shown that some of the risk factors for suicide in schizophrenia are similar to those for suicide in the general population, it has highlighted certain risk factors that are clearly specific to schizophrenia and its consequences.

The risk for suicide in men compared with women with schizophrenia of 1.57 is somewhat less than the ratio observed in the general populations of most countries. In contrast to the risk in the general population, being single or divorced was not associated with greater risk.

The living circumstances of patients appeared to be important, in that those living alone, or not living with their families, were at increased risk, a finding that might reflect the severity of the disorder.

Life events in the form of recent losses appear to be associated with suicide risk in patients, as is the case for suicide risk in general.

The most robust findings were of risk of suicide being strongly associated with affective disorders, such as depression; specific affective symptoms (agitation, sense of worthlessness and hopelessness); a history of suicidal thinking; threats of suicide; and (especially) non-fatal suicidal acts.

Further support for the importance of depression as a risk factor came from the positive association of risk with a family history of affective disorders. A family history of suicide was also a risk factor in the largest study that examined this area.

The meta-analysis provides some support for the idea that a higher level of education is associated with suicide risk, and this may also be the case with higher IQ. Fear of mental disintegration was also associated with increased risk.

Surprisingly, given the significance of alcohol misuse as a major risk factor for suicide in the general population, it does not appear to be a risk factor in schizophrenia. On the other hand, drug misuse or dependence was strongly associated with risk. Drug misuse is twice as common among people with schizophrenia as in the general population.

Suicide risk is considerably increased in patients who adhere poorly to treatment. Prevention of suicide is likely to result from active treatment of affective symptoms; improving compliance with treatment; use of medication that may have special anti-suicidal effects; and maintaining special vigilance in patients with risk factors, especially after significant loss events.

Publication: Hawton, K., Sutton, L., Haw, C., Sinclair, J. and Deeks, J.D. (2005) Schizophrenia and suicide: systematic review of risk factors. British Journal of Psychiatry, 187, 9-20.
On the web: bjp.rcpsych.org 

Advertise in this space for $10 per month. Contact us today.

Related Suicide News
Understanding gender differences in suicide methods
Countries with high happiness levels also have high suicide rates
More than half college students have suicidal thoughts
Sleep disturbances among the elderly linked to suicide
Genetic variations may predispose some men to suicidal thoughts during treatment for depression
Sleep disorder may cause suicidal tendencies
Suicide rate among NY's ethnic women population alarming
Suicide Risk associated with Pre- and Postnatal and Early Childhood Factors
Antidepressants are of questionable benefit in teenage suicide cases
Cancer survivors at risk for suicidal thoughts

Subscribe to Suicide Newsletter

Enter your email address:

 Additional information about the news article
The British Journal of Psychiatry is one of the world's leading psychiatric journal and an essential companion to clinical practice and research. It covers all branches of the subject, with an overriding concern to improve the prevention, investigation, diagnosis, treatment and care of mental illness, and the promotion of mental health throughout the world. In addition to the best international research papers, the journal incudes literature reviews, editorial, a comprehensive book review section and a lively and well-informed correspondence column. A series of supplements, free to subscribers, provides extensive in-depth coverage of selected areas. The British Journal of Psychiatry is available in print and online.
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

Contact us

RxPG Online



    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)